We use cookies to improve your experience on our website. By browsing this website, you agree to our use of cookies.
News - Cellvizio - Jul 5, 2017

PERSEE Study demonstrates applicability of Cellvizio in surgical interventions for digestive cancers, triggering milestone payment from BpiFrance